Cargando…
The Reduction in Gastric Atrophy after Helicobacter pylori Eradication Is Reduced by Treatment with Inhibitors of Gastric Acid Secretion
Background: Helicobacter pylori (H. pylori) eradication therapy may improve gastric atrophy and intestinal metaplasia, but the results of previous studies have not always been consistent. The aim of this study was to compare the histological changes of intestinal metaplasia and gastric atrophy among...
Autores principales: | Niikura, Ryota, Hayakawa, Yoku, Hirata, Yoshihiro, Ogura, Keiji, Fujishiro, Mitsuhiro, Yamada, Atsuo, Ushiku, Tetsuo, Konishi, Mitsuru, Fukayama, Masashi, Koike, Kazuhiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515232/ https://www.ncbi.nlm.nih.gov/pubmed/31003453 http://dx.doi.org/10.3390/ijms20081913 |
Ejemplares similares
-
Clinicopathological Features of Gastric Cancer with Autoimmune Gastritis
por: Arai, Junya, et al.
Publicado: (2022) -
Effect of aspirin use on gastric cancer incidence and survival: A systematic review and meta‐analysis
por: Niikura, Ryota, et al.
Publicado: (2019) -
Nonsteroidal anti‐inflammatory drugs prevent gastric cancer associated with the use of proton pump inhibitors after Helicobacter pylori eradication
por: Arai, Junya, et al.
Publicado: (2021) -
Distinct Features of Autoimmune Gastritis in Patients with Open-Type Chronic Gastritis in Japan
por: Tsuboi, Mayo, et al.
Publicado: (2020) -
Efficacy of Vonoprazan for Gastroesophageal Reflux Symptoms in Patients with Proton Pump Inhibitor-resistant Non-erosive Reflux Disease
por: Niikura, Ryota, et al.
Publicado: (2018)